Tumour marker levels in patients with chronic heart failure

European Journal of Heart Failure

Volumn 7, Issue 5, 2005, Pages 840-843

  Varol, Ercan ^a   Ozaydin, Mehmet ^b   Dogan, Abdullah ^b   Kosar, Feridun ^c  

^a Isparta Military Hospital   (Turkey)

^b SULEYMAN DEMIREL UNIVERSITY   (Turkey)

^c INONU UNIVERSITY   (Turkey)

Author keywords

CA 125; Heart failure; Tumour markers

Indexed keywords

CA 125 ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EVALUATION; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; MALE; PERICARDIAL EFFUSION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

AGED; ALPHA-FETOPROTEINS; CA-125 ANTIGEN; CA-15-3 ANTIGEN; CA-19-9 ANTIGEN; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 23744491703     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2004.12.008     Document Type: Article

References (26)

1. H.A. Fritsche Serum tumor markers for patient monitoring: a case-oriented approach illustrated with carcinoembryonic antigen Clin. Chem. 39 1993 2431 2434
2. S.E. Bates Clinical applications of serum tumor markers Ann. Intern. Med. 115 1991 623 638
3. P. Kenemans, C.A. Yedema, and G.G. Bon CA 125 in gynecological pathology: a review Eur. J. Obstet. Gynecol. Reprod. Biol. 49 1993 115 124
4. M.E. Vander Burg, F.B. Lammes, and J.J. Verwei CA 125 in ovarian cancer Neth. J. Med. 40 1992 36 51
5. E.H. Hopman, T.J. Helmerhorst, J.M. Bunfrer, and W.W. Ten Bukkel Huinink Highly elevated serum CA 125 levels in a patient with cardiac failure Eur. J. Obstet. Gynecol. Reprod. Biol. 48 1993 71 73
6. H. Nägele, M. Bahlu, R. Klapdor, D. Schaeperkoeter, and W. Rödiger CA 125 and its relation to cardiac function Am. Heart J. 137 1999 1044 1049
7. D. A'loia, P. Faggiano, and G. Aurigemma Serum levels of carbohydrate Antigen 125 in patients with chronic heart failure. Relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities and short-term prognosis J. Am. Coll. Cardiol. 41 2003 1805 1811
8. H.M. Turk, H. Pekdemir, and S. Buyukberber Serum CA 125 levels in patients with chronic heart failure and accompanying pleural fluid Tumor Biol. 24 2003 172 175
9. H. Nagele, M. Bahlo, R. Klapdor, and W. Rodiger Fluctuations of tumor markers in heart failure patients pre and post heart transplantation Anticancer Res. 19 4A 1999 2531 2534
10. P.T. Lavin, R.C. Knapp, G. Malkasion, C.W. Whitney, J.C. Berek, and R.C. Bast Jr. CA 125 for the monitoring of ovarian carcinoma during primary therapy Obstet. Gynecol. 69 1987 223 227
11. K. Sjovall, B. Nilsson, and N. Einhorn The significance of serum CA 125 elevation malignant and nonmalignant diseases Gynecol. Oncol. 85 2002 175 178
12. U. Saygili, S. Guclu, T. Uslu, O. Erten, and E. Doǧan The effect of ascites, mass volume, and peritoneal carcinomatosis on serum CA 125 levels in patients with ovarian carcinoma Int. J. Gynecol. Cancer 12 2002 438 442
13. A. Sevinç, S. Buyukberber, R. Sari, H.M. Turk, and M. Ates Elevated serum CA 125 levels in patients with nephrotic syndrome induced ascites Anticancer Res. 20 2000 1201 1204
14. A. Sevinc, S. Buyukberber, and R. Sari Elevated serum CA 125 levels: hepatitis or ascites? Gynecol. Oncol. 76 2000 141 142
15. A. Sevinc, S. Buukberber, R. Sari, Y. Kinoglu, H.M. Turk, and M. Ates Elevated serum CA 125 levels in hemodialysis patients with peritoneal, pleural or pericardial fluids Gynecol. Oncol. 76 2000 141 142
16. M. Epiney, C. Bertussa, A. Weil, A. Campana, and P. Bishof CA 125 production by peritoneum: in-vitro and in-vivo studies Hum. Reprod. 15 2000 1261 1265
17. I. Gullu, S. Yalcin, and G. Tekuzman Tumour markers in effusions: a comparative study of tumour marker levels in sera and effusion C.C. Travis Use of biomarkers in assessing health and environmental impacts of chemical pollutants 1993 Plenum New York 265 272
18. T. Seo, Y. Ikeda, and H. Onaka Usefulness of serum CA 125 measurement for monitoring pericardial effusion Jpn. Circ. J. 57 1993 489 494
19. M. Watanabe, T. Kanda, M. Takatama, T. Iwai, I. Naito, and T. Fukuda An autopsy case of malignant lymphoma with a high serum CA 125 level occurring only in the brain and the pericardium J. Med. 27 1996 221 227
20. P. Cacoub, H.D. Le Thi, B. Wechesler, C. Chapelon, A. Auperin, and I. Gandjbakch Chronic constrictive pericarditis responsible for an increase of CA 125 levels, two cases (in French) Presse Méd. 19 1990 1712 1714
21. J. Lindgren, P. Kuusela, P.E. Hellstrom, T. Petterson, and M. Klockars The ovarian cancer associated antigen CA 125 in patients with pleural effusions Eur. J. Cancer Clin. Oncol. 24 1988 737 739
22. A.G. Zeimet, F.A. Offner, and C. Marth Modulation of CA 125 release by inflammatory cytokines in human peritoneal mesothelial and ovarian cancer cells Anticancer Res. 17 1997 3129 3131
23. I. Kubonishi, K. Bandobaschi, N. Murata, H. Daibata, E. Ido, and H. Sunobe High serum level of CA 125 and interleukin-6 in a patient with Ki-1 lymphoma Br. J. Haematol. 98 1997 450 452
24. G.A. Mac Gowen, D.L. Mann, R.L. Kormos, A.M. Feldman, and S. Murali Circulating interleukin-6 in severe heart failure Am. J. Cardiol. 79 1997 1128 1131
25. R. Ferrari, T. Bachetti, and R. Confortini Tumor necrosis factor soluble receptors in patients with various degree of congestive heart failure Circulation 92 1995 1479 1486
26. F. Ko°ar, E. Varol, and M. Ileri Circulating cytokines and complements in chronic heart failure Angiology 50 5 1999 403 408